NASDAQ, ARWR - Arrowhead Pharma

Unless otherwise noted, (1) the term ?Arrowhead Research? refers to Arrowhead  Research Corporation, a Delaware corporation formerly known as InterActive  Group, Inc., (2) the terms ?Arrowhead,? the ?Company,? ?we,? ?us,? and ?our,?  refer to the ongoing business operations of Arrowhead Research and its  Subsidiaries, whether conducted through Arrowhead Research or a subsidiary of  the company Arrowhead Research, (3) the term ?ARC? refers to Arrowhead Research  Corporation, a privately-held California corporation with which Arrowhead  Research consummated a stock exchange transaction in January 2004, and (4) the  term ?Common Stock? refers to Arrowhead Research?s Common Stock and the term  ?stockholder(s)? refers to the holders of Common Stock or securities exercisable  for Common Stock.  The Company was originally incorporated in South Dakota in 1989, and was  reincorporated in Delaware in 2000 under the name InterActive, Inc.  (?InterActive?).  ...

Sector:	Health Care
Industry:	Biotechnology: Commercial Physical & Biological Resarch
P/E Ratio:	N/A
PEG Ratio:	N/A
EPS:	N/A
DivYield:	N/A
PtB:	3.3926
PtS:	11.15
EBITDA:	N/A
Shares:	138.1M
Market Cap:	2.268B
52wk range:	9.57 - 27.34

216.73.216.229
United States